AC Immune (ACIU) Research & Development (2016 - 2025)
Historic Research & Development for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$16.3 million.
- AC Immune's Research & Development rose 224.65% to -$16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.4 million, marking a year-over-year decrease of 407.71%. This contributed to the annual value of -$71.4 million for FY2024, which is 1602.44% down from last year.
- As of Q3 2025, AC Immune's Research & Development stood at -$16.3 million, which was up 224.65% from -$20.3 million recorded in Q2 2025.
- AC Immune's 5-year Research & Development high stood at -$14.0 million for Q3 2023, and its period low was -$21.8 million during Q4 2021.
- Its 5-year average for Research & Development is -$16.7 million, with a median of -$16.4 million in 2022.
- In the last 5 years, AC Immune's Research & Development surged by 2800.99% in 2022 and then crashed by 2454.07% in 2024.
- Quarter analysis of 5 years shows AC Immune's Research & Development stood at -$21.8 million in 2021, then rose by 28.01% to -$15.7 million in 2022, then dropped by 5.08% to -$16.5 million in 2023, then dropped by 9.15% to -$18.0 million in 2024, then grew by 9.32% to -$16.3 million in 2025.
- Its Research & Development stands at -$16.3 million for Q3 2025, versus -$20.3 million for Q2 2025 and -$17.7 million for Q1 2025.